Mutations in the TP53 gene also lead to increased CXCL1 expression in ovarian cancer [132], which is associated with increased NF-κB activation [132], as well as the direct attachment of p53 with a gain-of-function mutation to the CXCL1 promoter [133]. Here, NFKB1 is linked to ovarian carcinoma.